IP Library Assignment 064718/0868
Patent Assignment
Reel/Frame 064718/0868

Patent Security Agreement

Recorded: 2023-08-25 Pages: 8
Assignor
ADC THERAPEUTICS SA
Executed: 2023-06-29
Assignee
OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
399 PARK AVENUE, 38TH FLOOR, NEW YORK, NEW YORK, 10022
Covered Properties (5)
Combination Therapy with an Anti-CD25 Antibody-Drug Conjugate
Application: 16/605,708 →
Publication: US 2022/0016259
Pyrrolobenzodiazepine-Antibody Conjugates
Application: 17/380,859 →
Publication: US 2022/0016261
Dosage Regime
Application: 17/938,193 →
Publication: US 2023/0106885
Anti-Psma Conjugates
Application: 18/056,080 →
Publication: US 2023/0201366
Anti-Il-13RALPHA2 Conjugates
Application: 18/056,082 →
Publication: US 2023/0285580
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 15, 2020
From: WUERTHNER, JENS
To: ADC THERAPEUTICS SA
Reel/Frame 052405/0844 →
Assignment of Assignor's Interest Apr 15, 2020
From: VAN BERKEL, PATRICIUS HENDRIKUS CORNELIS; ZAMMARCHI, FRANCESCA; SKELTON, LISA
To: ADC THERAPEUTICS (UK) LIMITED
Reel/Frame 052408/0953 →
Assignment of Assignor's Interest Apr 15, 2020
From: FEINGOLD, JAY MARSHALL
To: ADC THERAPEUTICS AMERICA, INC.
Reel/Frame 052405/0916 →
Assignment of Assignor's Interest Apr 15, 2020
From: HARTLEY, JOHN
To: UNIVERSITY COLLEGE LONDON
Reel/Frame 052405/0881 →
Assignment of Assignor's Interest Apr 16, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 052420/0618 →
Assignment of Assignor's Interest Apr 16, 2020
From: ADC THERAPEUTICS AMERICA, INC.
To: ADC THERAPEUTICS SA
Reel/Frame 052420/0591 →
Assignment of Assignor's Interest Apr 16, 2020
From: UNIVERSITY COLLEGE LONDON
To: ADC THERAPEUTICS SA
Reel/Frame 052420/0549 →
Assignment of Assignor's Interest Apr 17, 2020
From: ADC THERAPEUTICS (UK) LIMITED
To: ADC THERAPEUTICS SA
Reel/Frame 052434/0682 →
Assignment of Assignor's Interest Apr 20, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 052441/0530 →
Assignment of Assignor's Interest Apr 20, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 052441/0497 →
Assignment of Assignor's Interest Apr 20, 2020
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 052442/0444 →
Security Interest May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Security Interest Jun 12, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P.
Reel/Frame 052925/0143 →
Termination and Release of Patent Security Agreement Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →
Assignment of Assignor's Interest Oct 6, 2022
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 061333/0537 →
Assignment of Assignor's Interest Oct 6, 2022
From: ADC THERAPEUTICS AMERICA, INC.
To: ADC THERAPEUTICS SA
Reel/Frame 061333/0501 →
Assignment of Assignor's Interest Oct 6, 2022
From: UNGAR, DAVID RODNEY; FEINGOLD, JAY MARSHALL
To: ADC THERAPEUTICS AMERICA, INC.
Reel/Frame 061333/0485 →
Patent Security Agreement Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →
Patent Security Agreement Dec 28, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 063738/0001 →
Assignment of Assignor's Interest May 3, 2023
From: ADC THERAPEUTICS SA
To: MEDIMMUNE LIMITED
Reel/Frame 063520/0819 →
Security Interest Jun 7, 2023
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTNISTIC MASTER FUND I, L.P.
Reel/Frame 063903/0707 →
Corrective Assignment to Correct the the Correct Assignee Name as Owl Rock Opportunistic Master Fund I, L.P... Previously Recorded at Reel: 063903 Frame: 0707. Assignor(S) Hereby Confirms the Security Interest. Jun 22, 2023
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 064057/0069 →